-

Integrant announces closure of Series A capital raise. Now exploring pre-IPO raise ahead of November listing

SYDNEY--(BUSINESS WIRE)--Integrant (proposed ticker: INGT) today announced the successful closure of its Series A capital raise, originally opened in April 2025. The round attracted strong investor interest, with responses described by the company as highly encouraging and reflective of growing confidence in its technology and strategic direction.

Integrant announces the successful closure of its Series A capital raise, significant progress in its AI platform development, and is now exploring a pre-IPO raise ahead of its planned Nasdaq listing (INGT).

Share

Since initiating the Series A, Integrant has achieved a series of technical milestones, including meaningful progress in the development of its artificial intelligence platform. Considering both the capital secured and these advancements, the company has reassessed its funding strategy. Management has determined that the original allocation framework established at the outset of the Series A is no longer aligned with current priorities and opportunities.

With the company currently targeting an initial public offering (IPO) in approximately seven months, Integrant is actively exploring a pre-IPO placement. This prospective round is intended to provide an opportunity for investors who were unable to participate in the Series A to engage with the company ahead of a potential public listing.

The pre-IPO raise is expected to support final-stage development, operational scaling, and market readiness initiatives as Integrant continues preparations for its targeted Nasdaq listing.

Investors seeking further information regarding the anticipated IPO or pre-IPO participation are encouraged to make direct contact with the company.

About Integrant

Integrant is a technology company developing integrated solutions across artificial intelligence, medical technology and biologics.

Forward-Looking Statements

This press release contains forward-looking statements, including statements regarding the proposed IPO and future fundraising activities. These statements are subject to risks and uncertainties, and actual results may differ materially. Integrant undertakes no obligation to update forward-looking statements, except as required by applicable law.

Contacts

Media Contact:
Adelaide Slater
Integrant Pty Ltd
Phone: +61 439 880 233
Email: media@integrant.com.au
Website: www.integrant.com.au
Investment Contact:
Email: Investor_relations@integrant.com.au

Integrant Pty Ltd


Release Summary
Integrant closes Series A, advances AI platform, and explores pre-IPO raise ahead of planned Nasdaq IPO (INGT) to support scaling.
Release Versions

Contacts

Media Contact:
Adelaide Slater
Integrant Pty Ltd
Phone: +61 439 880 233
Email: media@integrant.com.au
Website: www.integrant.com.au
Investment Contact:
Email: Investor_relations@integrant.com.au

Social Media Profiles
More News From Integrant Pty Ltd

Integrant Awarded Nasdaq Ticker “INGT” Ahead of Highly Anticipated IPO

SYDNEY--(BUSINESS WIRE)--Integrant (INGT) awarded Nasdaq ticker ahead IPO, advancing AI-driven regenerative medicine and orthopaedic therapies from Sydney Australia....
Back to Newsroom